GlassScriptPhysician profile
Gideon A Ladd
NPI 1225061906
$7,229.34
in general payments reported to CMS, 2019-2025
12 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,360 · 2022: $47.70 · 2023: $414 · 2024: $255 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $6,579.20 | 2021-2024 | Vasoview Hemopro 2 |
| Intuitive Surgical, INC. | $198.08 | 2021 | |
| Maquet Cardiovascular L.L.C. | $157.92 | 2021 | |
| Edwards Lifesciences Corporation | $85.85 | 2023-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Boston Scientific Corporation | $58.90 | 2023-2024 | Eluvia, Angiojet Ultra 5000a |
| W. L. Gore & Associates, INC. | $31.31 | 2025 | Gore Excluder Aaa Endoprosthesis |
| Novartis Pharmaceuticals Corporation | $28.44 | 2025 | |
| Silk Road Medical, INC. | $23.92 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Solventum Corporation | $23.47 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Heartflow, INC. | $22.22 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.31 | 2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.72 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gideon Ladd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.